How many insider declarations has Versant Ventures V, LLC filed?

Versant Ventures V, LLC has filed 8 public insider declarations with SEC (Form 4).

What is Versant Ventures V, LLC's role?

Versant Ventures V, LLC's reported role is not specified by the regulator across the filings.

Which companies does Versant Ventures V, LLC report trades for?

Versant Ventures V, LLC reports trades for 2 companies, including Repare Therapeutics Inc..

What is Versant Ventures V, LLC's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 2.8M€.

← Executives ★ Sign in to follow

VV

Versant Ventures V, LLC

Other

US·SEC (Form 4)

Repare Therapeutics Inc.Turnstone Biologics Corp.

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

€3m

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

1

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Browse the complete record of transactions filed by Versant Ventures V, LLC. Director active across 2 companies, notably Repare Therapeutics Inc.. Cumulatively, 8 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €2.8m. History available since 5 May 2021. The latest transaction was disclosed on 3 June 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.

Declarations8 total

●

Versant Ventures V, LLC

Executives25 Jul 2023Turnstone Biologics Corp.

2SEC ↗

2,528,864 sharesCommon StockSEC:0001209191-23-043527:0

▼

Versant Ventures V, LLC

Executives3 Jun 2022Repare Therapeutics Inc.

$3M25SEC ↗

250,000 shares@ US$12.2517100.0% of flowCommon SharesSEC:0000899243-22-021348:0

●